Is there a benefit for administration of antivenom following local and mild systemic reactions to Daboia (Vipera) Palaestinae snake bites?

References

• Aroch, I. and Harrus, S., 1999. Retrospective study of the epidemiological, clinical, haematological and biochemical findings in 109 dogs poisoned by Vipera xanthina palaestinae. Veterinary record, 144, 532–535.
   PubMed Web of Science ®Google Scholar
• Ben Abraham, R., et al., 2001. Snakebite poisoning in children – a call for unified clinical guidelines. European journal of emergency medicine, 8, 189–192.
   PubMedGoogle Scholar
• Bentur, Y. and Cahana, A., 2003. Unusual local complications of Vipera palaestinae bite. Toxicon, 41, 633–635.
   PubMed Web of Science ®Google Scholar
• Bentur, Y., et al., 1997. Delayed administration of Vipera xanthina palaestinae antivenin. Journal of toxicology clinical toxicology, 35, 257–261.
   PubMed Web of Science ®Google Scholar
• Bentur, Y., et al., 2010. Pediatric poisonings in Israel: National Poison Center data. The Israel medical association journal, 12, 554–559.
   PubMed Web of Science ®Google Scholar
• Bentur, Y., Raikhlin-Eisenkraft, B., and Galperin, M., 2004. Evaluation of antivenom therapy in Vipera palaestinae bites. Toxicon, 44, 53–57.
   PubMed Web of Science ®Google Scholar
• Bernstein, Y., 1988. Venomous snakes in Israel. Israel defence forces medical corps journal, 7.
   Google Scholar
• Coppola, M., and Hogan, D.E., 1992. Venomous snakes of southwest Asia. The American journal of emergency medicine, 10, 230–236.
   PubMed Web of Science ®Google Scholar
• Dart, R.C., et al., 1996. Validation of a severity score for the assessment of crotalid snakebite. Annals of emergency medicine, 27, 321–326.
   PubMed Web of Science ®Google Scholar
• Efrati, P., 1969. Clinical manifestations and treatment of viper bite in Israel. Toxicon, 7, 29–31.
   PubMed Web of Science ®Google Scholar
• Efrati, P., 1977. Viper bites. Family physician, 1, 94.
   Google Scholar
• Efrati, P., and Reif, L., 1953. Clinical and pathological observations of sixty-five cases of viper bite in Israel. The American journal of tropical medicine and hygiene, 2, 1085–1108.
   PubMed Web of Science ®Google Scholar
• Gitter, S., 1962. Toxicology and biochemistry of the venoms of some Israeli snakes. Dapim refuiim, 21, 610–613.
   PubMedGoogle Scholar
• Gitter, S., et al., 1957. Studies on electrophoretic fractions of Vipera xanthina palaestinae venom 1. The American journal of tropical medicine and hygiene, 6, 180–189.
   PubMed Web of Science ®Google Scholar
• Grotto, L., et al., 1967. Isolation of Vipera palaestinae hemorrhagin and distinction between its hemorrhagic and proteolytic activities. Biochimica et biophysica acta, 133, 356–362.
   PubMed Web of Science ®Google Scholar
• Hoffman, A., et al., 1993. Myocarditis following envenoming with Vipera palaestinae in two horses. Toxicon, 31, 1623–1628.
   PubMed Web of Science ®Google Scholar
• Huskisson, E.C., 1982. Measurement of pain. The journal of rheumatology, 9 (5), 768–769.
   PubMed Web of Science ®Google Scholar
• Kochva, E., 1998. Venomous snakes of Israel: ecology and snakebite. Public health reviews, 26, 209–232.
   PubMedGoogle Scholar
• Lurie, Y., and Bentur, Y., 2010. Vipera palaestinae bite and serum sickness during pregnancy. The journal of emergency medicine, 38, e67–e70.
   PubMedGoogle Scholar
• Mann, G., 1980. [Palestinian viper bite]. Harefuah, 99, 352–353.
   PubMedGoogle Scholar
• McKay, D.G., et al., 1970. The action of hemorrhagin and phospholipase derived from Vipera palaestinae venom on the microcirculation. Laboratory Investigation: a Journal of Technical Methods and Pathology, 22, 387–399.
   PubMed Web of Science ®Google Scholar
• Meitner, H., and Albers, M., 2012. Introducing safety-organized practice. National center on crime and delinquency. Available from: http://bayareaacademy.org/wpcontent/uploads/2013/05/SOP-Handout-Booklet-9-20-12.pdf [Accessed March 2017].
   Google Scholar
• Mendelssohn, H., 1963. On the biology of venomous snakes of Israel. Israel journal of zoology, 12, 143–170.
   Google Scholar
• Momic, T., et al., 2011. Pharmacological aspects of Vipera xanthina palaestinae venom. Toxins, 3, 1420–1432.
   PubMed Web of Science ®Google Scholar
• Moroz, C., 1998. Vipera palaestinae antivenin. Public health reviews, 26, 233–236.
   PubMedGoogle Scholar
• Moroz, C., de Vries, A., and Goldblum, N., 1966. Preparation of an antivenin against Vipera palaestinae venom with high antineurotoxic potency. Toxicon, 4, 205–208.
   PubMed Web of Science ®Google Scholar
• Moroz, C., Goldblum, N., and De Vries, A., 1963. Preparation of Vipera palaestinae antineurotoxin using carboxymethyl-cellulose-bound neurotoxin as antigen. Nature, 200, 697–698.
   PubMed Web of Science ®Google Scholar
• Moroz, C., Hahn, J., and de Vries, A., 1971. Neutralization of Vipera palaestinae hemorrhagin by antibody fragments. Toxicon, 9, 57–62.
   PubMed Web of Science ®Google Scholar
• Nakar, O., Ovadia, M., and Kochva, E., 1986. Isolation and characterization of a proteolytic factor from the venom of Vipera palaestinae. Toxicon, 24, 293–304.
   PubMed Web of Science ®Google Scholar
• Paret, G., et al., 1997. Vipera palaestinae snake envenomations: experience in children. Human & experimental toxicology, 16, 683–687.
   PubMed Web of Science ®Google Scholar
• Pivko-Levy, D., et al., 2017. Evaluation of antivenom therapy for Vipera palaestinae bites in children: experience of two large, tertiary care pediatric hospitals. Clinical toxicology, 55, 235–240.
   PubMed Web of Science ®Google Scholar
• Shemesh, I.Y., et al., 1998. Preliminary evaluation of Vipera palaestinae snake bite treatment in accordance to the severity of the clinical syndrome. Toxicon, 36, 867–873.
   PubMed Web of Science ®Google Scholar
• Shiloah, J., et al., 1973. Phospholipase B activity of a purified phospholipase A from Vipera palaestinae venom. Journal of lipid research, 14, 267–278.
   PubMed Web of Science ®Google Scholar
• Shulov, A.S., Primor, N., and Abraham, Z., 1987. Vipera xanthina palaestinae. In: The field guide to venomous animals in Israel. Israel: Academon & Zmora, Bitan, 18.
   Google Scholar
• Tirosh-Levy, S., et al., 2017. Daboia (Vipera) palaestinae envenomation in horses: clinical and hematological signs, risk factors for mortality and construction of a novel severity scoring system. Toxicon, 137, 58–64.
   PubMed Web of Science ®Google Scholar
• Werner, F.E., 1938. Verkannte Viper (Vipera palaestinae n. sp.). Zoologischer anzeiger, 122, 313–318.
   Google Scholar
• Winkler, E., Chovers, M., and Almog, S., 1992. V. Palestinae bites-clinical experience in Israel. Recent advances in toxicology research, 1, 329–336.
   Google Scholar